Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients
Clinical trial NCT02623946 · COMPLETED
Trial details
- NCT number
- NCT02623946
- Sponsor
- Clinique Neuro-Outaouais
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-01
- Primary completion
- 2020-12-09
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.